Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Search research articles

Home
Research Domains
Biomedical And Clinical Sciences
Oncology And Carcinogenesis
Predictive And Prognostic Markers
Current And Future Immunotherapeutic Approaches In Pancreatic Cancer Treatment.

Home
Research Domains
Biomedical And Clinical Sciences
Oncology And Carcinogenesis
Predictive And Prognostic Markers
Current And Future Immunotherapeutic Approaches In Pancreatic Cancer Treatment.

Related Experiment Video

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Current and future immunotherapeutic approaches in pancreatic cancer treatment.

Pooya Farhangnia^1,2,3,4, Hossein Khorramdelazad⁵, Hamid Nickho^2,3

¹Reproductive Sciences and Technology Research Center, Department of Immunology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.

Journal of Hematology & Oncology

|June 4, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Pancreatic cancer immunotherapy faces challenges due to the tumor's immunosuppressive microenvironment. This review explores various immunotherapy options and future directions for treating this deadly disease.

Keywords:

Adoptive cell therapy CAR NK cell therapy CAR T-cell therapy Cancer vaccine

More Related Videos

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Related Experiment Videos

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

Area of Science:

Oncology
Immunology
Cancer Research

Background:

Pancreatic cancer remains a leading cause of cancer death with a poor prognosis.
Early detection and effective treatment are challenging due to asymptomatic presentation and lack of reliable indicators.
Current treatments like chemotherapy and radiotherapy offer limited survival benefits.

Purpose of the Study:

To explain the immunosuppressive microenvironment of pancreatic cancer.
To highlight diverse immunotherapy options for pancreatic cancer treatment.
To discuss current challenges and future trends in pancreatic cancer immunotherapy.

Main Methods:

Review of contemporary knowledge on pancreatic cancer immunotherapy.
Explanation of the tumor microenvironment's role in treatment resistance.

Immune checkpoint blockade

Immune checkpoint inhibitor

Oncolytic virus therapy

Pancreatic cancer immunotherapy

Pancreatic ductal adenocarcinoma

Discussion of various immunotherapeutic strategies and their mechanisms.

Main Results:

The tumor microenvironment of pancreatic cancer is highly immunosuppressive, limiting treatment efficacy.
A wide array of immunotherapies show promise, including oncolytic viruses, engineered T-cell therapies (TCR and CAR T-cell), CAR NK cells, CIK cells, immune checkpoint inhibitors, and cancer vaccines.
Targeting myeloid cells and utilizing immunomodulators are also key strategies.

Conclusions:

Despite advancements, significant challenges remain in optimizing pancreatic cancer immunotherapy.
Overcoming the immunosuppressive tumor microenvironment is crucial for improving patient outcomes.
Future research should focus on novel therapeutic combinations and strategies to enhance immune response.